Serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination

Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan

(2021) Ryosuke Tateishi et al.   JOURNAL OF GASTROENTEROLOGY

Differential roles of GDF15 and FGF21 in systemic metabolic adaptation to the mitochondrial integrated stress response

(2021) Seul Gi Kang et al.   iScience

Japan Society of Hepatology guidelines for the management of hepatitis C virus infection: 2019 update

(2020)   HEPATOLOGY RESEARCH

Sex difference in the development of hepatocellular carcinoma after direct‐acting antiviral therapy in patients with HCV infection

(2020) Takao Watanabe et al.   JOURNAL OF MEDICAL VIROLOGY

Hepatic stellate cells in hepatocellular carcinoma promote tumor growth via growth differentiation factor 15 production

(2020) Yuta Myojin et al.   GASTROENTEROLOGY

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

(2019) Fabrice Carrat et al.   LANCET

Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of HCV-infected Cells and Liver to Identify Pathways Associated With Disease Development

(2019) Joachim Lupberger et al.   GASTROENTEROLOGY

Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction

(2019) Fasiha Kanwal et al.   GASTROENTEROLOGY

Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients with Baseline Cirrhosis or High FIB-4 Scores

(2019) George N. Ioannou et al.   GASTROENTEROLOGY

Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC Guidelines) a 2019 update

(2019) Norihiro Kokudo et al.   HEPATOLOGY RESEARCH

Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

(2019) Marc G. Ghany et al.   HEPATOLOGY

HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma

(2018) George N. Ioannou et al.   JOURNAL OF HEPATOLOGY

The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases

(2018) Vicky W.W. Tsai et al.   Cell Metabolism

Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals

(2018) Andrea Casadei Gardini et al.   DIGESTIVE AND LIVER DISEASE

Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C

(2018) George N. Ioannou et al.   JOURNAL OF HEPATOLOGY

Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

(2017) Fasiha Kanwal et al.   GASTROENTEROLOGY

Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada

(2017) Naveed Z. Janjua et al.   JOURNAL OF HEPATOLOGY

Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C

(2017) Hiroko Nagata et al.   JOURNAL OF HEPATOLOGY

Oxidative Stress and Immune Responses During Hepatitis C Virus Infection in Tupaia belangeri

(2017) Mohammad Enamul Hoque Kayesh et al.   Scientific Reports

Association of Serum Level of Growth Differentiation Factor 15 with Liver Cirrhosis and Hepatocellular Carcinoma

(2015) Xiuying Liu et al.   PLoS One

Post-treatment Levels of α-Fetoprotein Predict Incidence of Hepatocellular Carcinoma After Interferon Therapy

(2013) Tsugiko Oze et al.   Clinical Gastroenterology and Hepatology

Bak deficiency inhibits liver carcinogenesis: A causal link between apoptosis and carcinogenesis

(2012) Hayato Hikita et al.   JOURNAL OF HEPATOLOGY

Proteomics analysis of mitochondrial proteins reveals overexpression of a mitochondrial protein chaperon, prohibitin, in cells expressing hepatitis C virus core protein

(2009) Takeya Tsutsumi et al.   HEPATOLOGY

HCV Induces Oxidative and ER Stress, and Sensitizes Infected Cells to Apoptosis in SCID/Alb-uPA Mice

(2009) Michael A. Joyce et al.   PLoS Pathogens